Illumina Announces Multi-Million Dollar Agreement with Erasmus Medical Center.
Illumina Inc. announced that Erasmus Medical Center in Rotterdam has purchased Infinium HD (High-Density) Human610-Quad BeadChips for the analysis of 10,000 samples and a third scanner to support the Generation R Study. Designed to identify early environmental and genetic causes of normal and abnormal growth, development, and health from fetal life until young adulthood, the Generation R Study is a population-based prospective cohort study of almost 10,000 children and their parents. The Generation R Study is funded by the Erasmus Medical Center, the Dutch government, and other industry partners.
